Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine
- PMID: 29029303
- PMCID: PMC5853975
- DOI: 10.1093/infdis/jix484
Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine
Keywords: adjuvant; glycoprotein E; influenza vaccine; re-vaccination; zoster vaccine.
Comment on
-
Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.J Infect Dis. 2017 Dec 12;216(11):1343-1351. doi: 10.1093/infdis/jix482. J Infect Dis. 2017. PMID: 29029122 Free PMC article. Clinical Trial.
-
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older.J Infect Dis. 2017 Dec 12;216(11):1352-1361. doi: 10.1093/infdis/jix481. J Infect Dis. 2017. PMID: 29029224 Free PMC article. Clinical Trial.
References
-
- Watson CP, Morshead C, Van der Kooy D, Deck J, Evans RJ. Post-herpetic neuralgia: post-mortem analysis of a case. Pain 1988; 34:129–38. - PubMed
-
- Dworkin RH, Johnson RW, Breuer J et al. . Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(Suppl 1):S1–26. - PubMed
-
- Whitley RJ, Volpi A, McKendrick M, Wijck Av, Oaklander AL. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol 2010; 48(Suppl 1):S20–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
